Category

Blastoma

Blastoma

Oncotarget: Modulating Tau Post-translational modifications and cytoskeletal network

IMAGE: EGCG maintains neuronal cell cytoskeleton integrity. Methyl glyoxal treatment leads to glycation of actin and microtubules leading to hampered growth of neuritic extensions and microtubule organization. Microtubule stabilization by +TIP... view more  Credit: Correspondence to - Subashchandrabose Chinnathambi - s.chinnathambi@ncl.res.in Oncotarget published "Epigallocatechin-3-gallate modulates Tau Post-translational modifications and cytoskeletal network"…
bubmag
July 12, 2021
Blastoma

Woman Loses 6-Year Battle With Mouth Tumor

A 38-year-old Haitian woman presents to a Florida emergency department in April 2018 reporting pain on the right side of her abdomen, where she can feel a large lump. She tells clinicians she has had significant swelling in her abdomen, despite experiencing weight loss. After palpation of her abdomen confirms…
bubmag
July 4, 2021
Blastoma

The Cancer Custodians

Part of Dennis Plenker’s daily job is growing cancer. And a variety of different ones, too. Depending on the day and the project, different tumors may burgeon in the petri dishes stocked in the Cold Spring Harbor Laboratory where Plenker works as a research investigator. They might be aggressive breast…
bubmag
June 23, 2021
Blastoma

Oncotarget: Piperlongumine promotes death of retinoblastoma cancer cells

IMAGE: Effects of PL on cell cycle-regulatory factors in WERI-Rb and Y79 cells. (A) The expression of CDC25C, CDK1, CCNA2, CCNB1, CDKN1A and CDKN1B was measured at mRNA levels using real... view more  Credit: Correspondence to - Nathalie Allaman-Pillet - nathalie.allaman@gmail.com Oncotarget published "Piperlongumine promotes death of retinoblastoma cancer cells" which…
bubmag
May 31, 2021
Blastoma

Eisai and Merck & Co., Inc., Kenilworth, N.J., U.S.A. Receive Priority Review From FDA for LENVIMA (lenvatinib) Plus KEYTRUDA (pembrolizumab) Applications

Home Press release May 07, 2021 11:08 JST Source: Eisai Eisai and Merck & Co., Inc., Kenilworth, N.J., U.S.A. Receive Priority Review From FDA for LENVIMA (lenvatinib) Plus KEYTRUDA (pembrolizumab) Applications For Advanced Renal Cell Carcinoma and for Advanced Endometrial CarcinomaApplications Based on Progression-Free Survival, Overall Survival, and Objective Response…
bubmag
May 7, 2021
Blastoma

World-first discovery paves way to new cancer treatment

Credit: CC0 Public Domain Australian researchers have discovered a new way to target an aggressive childhood cancer, neuroblastoma, one of the most common and dangerous cancers in young children. The discovery may also have important implications for some other aggressive cancers in children, including certain brain tumours, as well as…
bubmag
March 26, 2021